- Home
- ASPN vs SAGE Comparison
ASPN vs SAGE Comparison
Compare ASPN & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- SAGE
- Stock Information
- Founded
- ASPN 2001
- SAGE 2010
- Country
- ASPN United States
- SAGE United States
- Employees
- ASPN N/A
- SAGE N/A
- Industry
- ASPN RETAIL: Building Materials
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- ASPN Consumer Discretionary
- SAGE Health Care
- Exchange
- ASPN Nasdaq
- SAGE Nasdaq
- Market Cap
- ASPN 486.5M
- SAGE 571.7M
- IPO Year
- ASPN 2014
- SAGE 2014
- Fundamental
- Price
- ASPN $6.16
- SAGE $9.11
- Analyst Decision
- ASPN Strong Buy
- SAGE Hold
- Analyst Count
- ASPN 10
- SAGE 18
- Target Price
- ASPN $21.78
- SAGE $10.06
- AVG Volume (30 Days)
- ASPN 1.4M
- SAGE 2.8M
- Earning Date
- ASPN 08-06-2025
- SAGE 07-30-2025
- Dividend Yield
- ASPN N/A
- SAGE N/A
- EPS Growth
- ASPN N/A
- SAGE N/A
- EPS
- ASPN N/A
- SAGE N/A
- Revenue
- ASPN $436,921,000.00
- SAGE $47,404,000.00
- Revenue This Year
- ASPN N/A
- SAGE $102.21
- Revenue Next Year
- ASPN $24.31
- SAGE $43.01
- P/E Ratio
- ASPN N/A
- SAGE N/A
- Revenue Growth
- ASPN 51.90
- SAGE N/A
- 52 Week Low
- ASPN $4.16
- SAGE $4.62
- 52 Week High
- ASPN $33.15
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- ASPN 52.87
- SAGE 71.91
- Support Level
- ASPN $5.75
- SAGE $9.04
- Resistance Level
- ASPN $6.36
- SAGE $9.30
- Average True Range (ATR)
- ASPN 0.31
- SAGE 0.15
- MACD
- ASPN -0.00
- SAGE 0.05
- Stochastic Oscillator
- ASPN 62.13
- SAGE 92.35
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.